Daisuke Hazama, M., Kenji Nakahama, M., Hiroaki Kodama, M., Akito Miyazaki, M., Koichi Azuma, M., Yosuke Kawashima, M., . . . Motoko Tachihara, M. (2024, January). Effectiveness and Safety of Immune Checkpoint Inhibitors Alone or in Combination With Chemotherapy in Pulmonary Sarcomatoid Carcinoma. JTO Clinical and Research Reports.
Chicago Style (17th ed.) CitationDaisuke Hazama, MD, et al. "Effectiveness and Safety of Immune Checkpoint Inhibitors Alone or in Combination With Chemotherapy in Pulmonary Sarcomatoid Carcinoma." JTO Clinical and Research Reports Jan. 2024.
MLA (9th ed.) CitationDaisuke Hazama, MD, et al. "Effectiveness and Safety of Immune Checkpoint Inhibitors Alone or in Combination With Chemotherapy in Pulmonary Sarcomatoid Carcinoma." JTO Clinical and Research Reports, Jan. 2024.
